Drugs / REcycled CartiLage Auto/Allo IMplantation
REcycled CartiLage Auto/Allo IMplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03672825 | Sep 2018 → May 2024 | cartilage development disorder | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | REcycled CartiLage Auto/Allo IMplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03672825 ↗ |
| Modality | Cell therapy | “allogeneic culture-expanded adipose-derived mesenchymal stem cells (AMSCs) combined with autologous cartilage cells” NCT03672825 ↗ |
| Route | Other | “suspended in fibrin glue for application to the debrided osteochondral defect” NCT03672825 ↗ |